Results 331 to 340 of about 194,651 (386)

Clinical characteristics of autoimmune GFAP astrocytopathy.

Journal of Neuroimmunology, 2019
The clinical features of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy remain to be elucidated. We describe here the clinical features of 14 patients with GFAP astrocytopathy confirmed by detection of GFAP-IgG in cerebrospinal fluid ...
A. Kimura, Akira Takekoshi, N. Yoshikura, Y. Hayashi, T. Shimohata   +4 more
semanticscholar   +3 more sources

Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

Alzheimer's & Dementia, 2022
Plasma amyloid beta (Aβ)1‐42/Aβ1‐40 ratio, phosphorylated‐tau181 (p‐tau181), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) are putative blood biomarkers for Alzheimer's disease (AD).
P. Chatterjee, S. Pedrini, J. Doecke, R. Thota, V. Villemagne, V. Doré, Abhayjeet Singh, Penghao Wang, S. Rainey-Smith, C. Fowler, K. Taddei, H. Sohrabi, M. Molloy, D. Ames, P. Maruff, C. Rowe, C. Masters, R. Martins   +17 more
semanticscholar   +1 more source

Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion

Journal of Neurology Neurosurgery & Psychiatry, 2022
Objective Reactive astrogliosis is a hallmark of Alzheimer’s disease (AD) and frontotemporal dementia (FTD) but differences between the diseases and time course are unclear.
P. Oeckl, S. Anderl-Straub, C. V. von Arnim, I. Baldeiras, J. Diehl-Schmid, T. Grimmer, S. Halbgebauer, Anna M Kort, M. Lima, Tainá M Marques, M. Ortner, I. Santana, P. Steinacker, M. Verbeek, A. Volk, A. Ludolph, M. Otto   +16 more
semanticscholar   +1 more source

GFAP transgenic zebrafish

Gene Expression Patterns, 2006
We have generated transgenic zebrafish that express green fluorescent protein (GFP) in glial cells driven by the zebrafish glial fibrillary acidic protein (GFAP) regulatory elements. Transgenic lines Tg(gfap:GFP) were generated from three founders; the results presented here are from the mi2001 line.
Rebecca L, Bernardos, Pamela A, Raymond
openaire   +2 more sources

Anti-GFAP Antibody-Associated Hypertrophic Pachymeningitis

Neuropediatrics, 2022
Abstract Background Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is an inflammatory central nervous system (CNS) disorder that usually presents as steroid responsive encephalitis, meningitis, myelitis, or meningoencephalomyelitis.
Chengbing Tan, Min Zhong, Zhengxiong Yao, Siqi Hong, Li Jiang, Yan Jiang   +5 more
openaire   +2 more sources

GFAP IgG associated inflammatory polyneuropathy

Journal of Neuroimmunology, 2020
GFAP (glial fibrillary acidic protein)-IgG is predominantly associated with meningoencephalomyelitis, and neuropathy presentations are rare.We reviewed clinical, electrodiagnostic and histopathological presentations of GFAP-IgG associated peripheral neuropathy.We identified six cases, five of whom had peripheral neuropathy as the initial presentation ...
Pritikanta, Paul, Andrew, McKeon, Sean J, Pittock, Christopher J, Klein, Shailee, Shah, Michel, Toledano, John R, Mills, Divyanshu, Dubey   +7 more
openaire   +2 more sources

Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.

Multiple Sclerosis and Related Disorders, 2021
BACKGROUND Astrocytes and microglial cells are now recognized as active players in contributing to the diffuse neuroaxonal damage associated with disease progression of multiple sclerosis (MS). The serum level of glial fibrillary acidic protein (GFAP), a
M. Saraste, Svetlana Bezukladova, M. Matilainen, M. Sucksdorff, J. Kuhle, D. Leppert, L. Airas   +6 more
semanticscholar   +1 more source